Last 12 months
Inside the activity.
0 purchase rows · 31 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 11 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 15 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 3 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 25, 2024 Filed Jan 26, 2024 20:50 UTC |
Jejurikar ShaileshChief Operating Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 31,275 | $0.00 Strike: $80.29 | $0.00 |
DisclosureSEC source: 0001127602-24-002247 · form4.xml · derivative · entry 7 Jejurikar Shailesh · CIK 0001746310 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 31,275 shares Expires 2026-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 25, 2024 Filed Jan 26, 2024 20:50 UTC |
Jejurikar ShaileshChief Operating Officer
|
SaleCommon Stock | 31,275 | $154.90 | $4,844,497.50 |
DisclosureSEC source: 0001127602-24-002247 · form4.xml · nonDerivative · entry 2 Jejurikar Shailesh · CIK 0001746310 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,623.4397 Read SEC document |
| January 25, 2024 Filed Jan 26, 2024 20:50 UTC |
Jejurikar ShaileshChief Operating Officer
|
Exercise / conversionCommon Stock | 31,275 | $80.29 | $2,511,069.75 |
DisclosureSEC source: 0001127602-24-002247 · form4.xml · nonDerivative · entry 1 Jejurikar Shailesh · CIK 0001746310 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,898.4397 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 25, 2024 Filed Jan 26, 2024 20:53 UTC |
Purushothaman BalajiChief Human Resources Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 14,000 | $0.00 Strike: $80.29 | $0.00 |
DisclosureSEC source: 0001127602-24-002250 · form4.xml · derivative · entry 4 Purushothaman Balaji · CIK 0001957262 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,369 Underlying: Common Stock · 14,000 shares Expires 2026-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 25, 2024 Filed Jan 26, 2024 20:53 UTC |
Purushothaman BalajiChief Human Resources Officer
|
SaleCommon Stock | 14,000 | $154.61 | $2,164,523.20 |
DisclosureSEC source: 0001127602-24-002250 · form4.xml · nonDerivative · entry 2 Purushothaman Balaji · CIK 0001957262 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,478.004 F1 · price: Weighted average price of the shares sold. The price range was $154.43 to $154.73. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| January 25, 2024 Filed Jan 26, 2024 20:53 UTC |
Purushothaman BalajiChief Human Resources Officer
|
Exercise / conversionCommon Stock | 14,000 | $80.29 | $1,124,060.00 |
DisclosureSEC source: 0001127602-24-002250 · form4.xml · nonDerivative · entry 1 Purushothaman Balaji · CIK 0001957262 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,478.004 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 24, 2024 Filed Jan 26, 2024 20:47 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 64,289 | $0.00 Strike: $91.07 | $0.00 |
DisclosureSEC source: 0001127602-24-002244 · form4.xml · derivative · entry 6 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 64,289 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 24, 2024 Filed Jan 26, 2024 20:47 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
SaleCommon Stock | 64,289 | $153.20 | $9,849,241.95 |
DisclosureSEC source: 0001127602-24-002244 · form4.xml · nonDerivative · entry 3 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 973.189 F2 · price: Weighted average price of the shares sold. The price range was $153.1201 to $153.225. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| January 24, 2024 Filed Jan 26, 2024 20:47 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
Exercise / conversionCommon Stock | 64,289 | $91.07 | $5,854,799.23 |
DisclosureSEC source: 0001127602-24-002244 · form4.xml · nonDerivative · entry 2 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,262.189 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 24, 2024 Filed Jan 26, 2024 20:47 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
SaleCommon Stock | 10,154 | $153.91 | $1,562,802.14 |
DisclosureSEC source: 0001127602-24-002244 · form4.xml · nonDerivative · entry 1 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 973.189 F1 · price: Weighted average price of the shares sold. The price range was $153.91 to $153.911. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| January 24, 2024 Filed Jan 26, 2024 20:55 UTC |
Pritchard Marc S.Chief Brand Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 101,704 | $0.00 Strike: $78.66 | $0.00 |
DisclosureSEC source: 0001127602-24-002253 · form4.xml · derivative · entry 8 Pritchard Marc S. · CIK 0001440364 · Chief Brand Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 101,704 shares Expires 2024-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 24, 2024 Filed Jan 26, 2024 20:55 UTC |
Pritchard Marc S.Chief Brand Officer
|
SaleCommon Stock | 101,704 | $153.57 | $15,618,286.63 |
DisclosureSEC source: 0001127602-24-002253 · form4.xml · nonDerivative · entry 2 Pritchard Marc S. · CIK 0001440364 · Chief Brand Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 163,428.3946 F1 · price: Weighted average price of the shares sold. The price range was $152.65 to $154.17. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| January 24, 2024 Filed Jan 26, 2024 20:55 UTC |
Pritchard Marc S.Chief Brand Officer
|
Exercise / conversionCommon Stock | 101,704 | $78.66 | $8,000,036.64 |
DisclosureSEC source: 0001127602-24-002253 · form4.xml · nonDerivative · entry 1 Pritchard Marc S. · CIK 0001440364 · Chief Brand Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 265,132.3946 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 12, 2023 Filed Dec 13, 2023 18:30 UTC |
Allen Bertrand MarcDirector
|
GrantCommon Stock | 206 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-029532 · form4.xml · nonDerivative · entry 1 Allen Bertrand Marc · CIK 0001632131 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,106.9775 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| December 12, 2023 Filed Dec 13, 2023 18:40 UTC |
Biggs M. BrettDirector
|
GrantCommon Stock | 185 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-029534 · form4.xml · nonDerivative · entry 1 Biggs M. Brett · CIK 0001662848 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,714.4452 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| December 12, 2023 Filed Dec 13, 2023 18:42 UTC |
Braly Angela FDirector
|
GrantCommon Stock | 240 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-029535 · form4.xml · nonDerivative · entry 1 Braly Angela F · CIK 0001321458 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,936.881 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) and shares acquired through the issuer's dividend reinvestment plan. Read SEC document |
| December 12, 2023 Filed Dec 13, 2023 18:44 UTC |
JIMENEZ JOSEPHDirector
|
GrantCommon Stock | 326 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-029536 · form4.xml · nonDerivative · entry 1 JIMENEZ JOSEPH · CIK 0001199095 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,015.9942 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| December 12, 2023 Filed Dec 13, 2023 18:45 UTC |
LUNDGREN TERRY JDirector
|
GrantCommon Stock | 249 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-029537 · form4.xml · nonDerivative · entry 1 LUNDGREN TERRY J · CIK 0001184471 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,908.6966 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) and shares acquired through the issuer's dividend reinvestment plan. Read SEC document |
| December 12, 2023 Filed Dec 13, 2023 18:47 UTC |
McCarthy Christine MDirector
|
GrantCommon Stock | 206 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-029538 · form4.xml · nonDerivative · entry 1 McCarthy Christine M · CIK 0001332169 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,583.3945 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock & Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| December 12, 2023 Filed Dec 13, 2023 18:48 UTC |
Portman Robert JonesDirector
|
GrantCommon Stock | 52 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-029539 · form4.xml · nonDerivative · entry 1 Portman Robert Jones · CIK 0001973769 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,678.3222 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units Read SEC document |
| December 12, 2023 Filed Dec 13, 2023 18:49 UTC |
WOERTZ PATRICIA ADirector
|
GrantCommon Stock | 257 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-029540 · form4.xml · nonDerivative · entry 1 WOERTZ PATRICIA A · CIK 0001194945 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,915.1279 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units. Read SEC document |
| December 12, 2023 Filed Dec 13, 2023 18:53 UTC |
Kempczinski Christopher JDirector
|
GrantCommon Stock | 206 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-029541 · form4.xml · nonDerivative · entry 1 Kempczinski Christopher J · CIK 0001598115 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,314.9082 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units Read SEC document |
| December 12, 2023 Filed Dec 14, 2023 20:18 UTC |
McEvoy AshleyDirector
|
GrantCommon Stock | 1,247 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-029613 · form4.xml · nonDerivative · entry 1 McEvoy Ashley · CIK 0001745936 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,247 F1 · price: Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 15:41 UTC |
Aguilar Moses Victor JavierChf Rsch, Dev & Innov Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 33.4063 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-029083 · form4.xml · derivative · entry 6 Aguilar Moses Victor Javier · CIK 0001825382 · Chf Rsch, Dev & Innov Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 517.5937 Underlying: Common Stock · 33.4063 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2023. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 15:41 UTC |
Aguilar Moses Victor JavierChf Rsch, Dev & Innov Officer
|
Tax withholdingCommon Stock | 33.4063 | $149.40 | $4,990.90 |
DisclosureSEC source: 0001127602-23-029083 · form4.xml · nonDerivative · entry 2 Aguilar Moses Victor Javier · CIK 0001825382 · Chf Rsch, Dev & Innov Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,800.2794 F2 · shares: Shares withheld to cover taxes on previous Restricted Stock Unit grant. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 15:41 UTC |
Aguilar Moses Victor JavierChf Rsch, Dev & Innov Officer
|
Exercise / conversionCommon Stock | 33.4063 | $149.40 | $4,990.90 |
DisclosureSEC source: 0001127602-23-029083 · form4.xml · nonDerivative · entry 1 Aguilar Moses Victor Javier · CIK 0001825382 · Chf Rsch, Dev & Innov Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,833.6857 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock and shares acquired through the issuer's dividend reinvestment plan. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 15:42 UTC |
Keith R. AlexandraCEO - Beauty
|
Tax withholdingCommon Stock | 19.2339 | $149.40 | $2,873.54 |
DisclosureSEC source: 0001127602-23-029084 · form4.xml · nonDerivative · entry 1 Keith R. Alexandra · CIK 0001710268 · CEO - Beauty 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 5,600.9321 F1 · shares: Shares withheld to cover taxes on previous Restricted Stock Unit grant. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 15:44 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
Exercise / conversionRestricted Stock Units · Derivative | 56.6895 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-029085 · form4.xml · derivative · entry 6 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 903.3105 Underlying: Common Stock · 56.6895 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2023. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 15:44 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
Tax withholdingCommon Stock | 56.6895 | $149.40 | $8,469.41 |
DisclosureSEC source: 0001127602-23-029085 · form4.xml · nonDerivative · entry 2 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,127.189 F2 · shares: Shares withheld to cover taxes on previous Restricted Stock Unit grant. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 15:44 UTC |
Francisco Ma. FatimaCEO - Baby, Fem & Family Care
|
Exercise / conversionCommon Stock | 56.6895 | $149.40 | $8,469.41 |
DisclosureSEC source: 0001127602-23-029085 · form4.xml · nonDerivative · entry 1 Francisco Ma. Fatima · CIK 0001747222 · CEO - Baby, Fem & Family Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,183.8785 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 15:46 UTC |
Pritchard Marc S.Chief Brand Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 80.985 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-029086 · form4.xml · derivative · entry 9 Pritchard Marc S. · CIK 0001440364 · Chief Brand Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 991.015 Underlying: Common Stock · 80.985 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2023. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 15:46 UTC |
Pritchard Marc S.Chief Brand Officer
|
Tax withholdingCommon Stock | 80.985 | $149.40 | $12,099.16 |
DisclosureSEC source: 0001127602-23-029086 · form4.xml · nonDerivative · entry 2 Pritchard Marc S. · CIK 0001440364 · Chief Brand Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 163,428.3946 F2 · shares: Shares withheld to cover taxes on previous Restricted Stock Unit grant. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 15:46 UTC |
Pritchard Marc S.Chief Brand Officer
|
Exercise / conversionCommon Stock | 80.985 | $149.40 | $12,099.16 |
DisclosureSEC source: 0001127602-23-029086 · form4.xml · nonDerivative · entry 1 Pritchard Marc S. · CIK 0001440364 · Chief Brand Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 163,509.3796 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 15:49 UTC |
Moeller Jon RDirector · Chairman, President and CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 154.8838 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-029087 · form4.xml · derivative · entry 8 Moeller Jon R · CIK 0001450613 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,989.1162 Underlying: Common Stock · 154.8838 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2023. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 15:49 UTC |
Moeller Jon RDirector · Chairman, President and CEO
|
Tax withholdingCommon Stock | 211.305 | $149.40 | $31,568.97 |
DisclosureSEC source: 0001127602-23-029087 · form4.xml · nonDerivative · entry 4 Moeller Jon R · CIK 0001450613 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 262,399.2732 F2 · shares: Shares withheld to cover taxes on previous Restricted Stock Unit grant. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 15:49 UTC |
Moeller Jon RDirector · Chairman, President and CEO
|
Tax withholdingCommon Stock | 1,695.1714 | $149.40 | $253,258.61 |
DisclosureSEC source: 0001127602-23-029087 · form4.xml · nonDerivative · entry 3 Moeller Jon R · CIK 0001450613 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 262,610.5782 F2 · shares: Shares withheld to cover taxes on previous Restricted Stock Unit grant. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 15:49 UTC |
Moeller Jon RDirector · Chairman, President and CEO
|
Tax withholdingCommon Stock | 154.8838 | $149.40 | $23,139.64 |
DisclosureSEC source: 0001127602-23-029087 · form4.xml · nonDerivative · entry 2 Moeller Jon R · CIK 0001450613 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 264,305.7496 F2 · shares: Shares withheld to cover taxes on previous Restricted Stock Unit grant. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 15:49 UTC |
Moeller Jon RDirector · Chairman, President and CEO
|
Exercise / conversionCommon Stock | 154.8838 | $149.40 | $23,139.64 |
DisclosureSEC source: 0001127602-23-029087 · form4.xml · nonDerivative · entry 1 Moeller Jon R · CIK 0001450613 · Director · Chairman, President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 264,460.6334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 15:51 UTC |
Jejurikar ShaileshChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 47.5786 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-029088 · form4.xml · derivative · entry 9 Jejurikar Shailesh · CIK 0001746310 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 612.4214 Underlying: Common Stock · 47.5786 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2023. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 15:51 UTC |
Jejurikar ShaileshChief Operating Officer
|
Tax withholdingCommon Stock | 47.5786 | $149.40 | $7,108.24 |
DisclosureSEC source: 0001127602-23-029088 · form4.xml · nonDerivative · entry 3 Jejurikar Shailesh · CIK 0001746310 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,623.4397 F1 · shares: Shares withheld to cover taxes on previous Restricted Stock Unit grant. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 15:51 UTC |
Jejurikar ShaileshChief Operating Officer
|
Exercise / conversionCommon Stock | 47.5786 | $149.40 | $7,108.24 |
DisclosureSEC source: 0001127602-23-029088 · form4.xml · nonDerivative · entry 2 Jejurikar Shailesh · CIK 0001746310 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,671.0183 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 15:51 UTC |
Jejurikar ShaileshChief Operating Officer
|
Tax withholdingCommon Stock | 574.6868 | $149.40 | $85,858.21 |
DisclosureSEC source: 0001127602-23-029088 · form4.xml · nonDerivative · entry 1 Jejurikar Shailesh · CIK 0001746310 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,623.4397 F1 · shares: Shares withheld to cover taxes on previous Restricted Stock Unit grant. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 15:53 UTC |
Janzaruk Matthew W.SVP - Chief Accounting Officer
|
Tax withholdingCommon Stock | 7.0861 | $149.40 | $1,058.66 |
DisclosureSEC source: 0001127602-23-029089 · form4.xml · nonDerivative · entry 1 Janzaruk Matthew W. · CIK 0001910008 · SVP - Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 623.1092 F1 · shares: Shares withheld to cover taxes on previous Restricted Stock Unit grant. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 15:55 UTC |
Davis Jennifer L.CEO - Health Care
|
Exercise / conversionRestricted Stock Units · Derivative | 47.5786 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-029090 · form4.xml · derivative · entry 5 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 743.4214 Underlying: Common Stock · 47.5786 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2023. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 15:55 UTC |
Davis Jennifer L.CEO - Health Care
|
Tax withholdingCommon Stock | 47.5786 | $149.40 | $7,108.24 |
DisclosureSEC source: 0001127602-23-029090 · form4.xml · nonDerivative · entry 2 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,255.6418 F2 · shares: Shares withheld to cover taxes on previous Restricted Stock Unit grant. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 15:55 UTC |
Davis Jennifer L.CEO - Health Care
|
Exercise / conversionCommon Stock | 47.5786 | $149.40 | $7,108.24 |
DisclosureSEC source: 0001127602-23-029090 · form4.xml · nonDerivative · entry 1 Davis Jennifer L. · CIK 0001916665 · CEO - Health Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,303.2204 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 16:16 UTC |
Schulten AndreChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 69.8496 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-029092 · form4.xml · derivative · entry 5 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 907.1504 Underlying: Common Stock · 69.8496 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2023. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 16:16 UTC |
Schulten AndreChief Financial Officer
|
Tax withholdingCommon Stock | 69.8496 | $149.40 | $10,435.53 |
DisclosureSEC source: 0001127602-23-029092 · form4.xml · nonDerivative · entry 2 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,649.7211 F2 · shares: Shares withheld to cover taxes on previous Restricted Stock Unit grant. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 16:16 UTC |
Schulten AndreChief Financial Officer
|
Exercise / conversionCommon Stock | 69.8496 | $149.40 | $10,435.53 |
DisclosureSEC source: 0001127602-23-029092 · form4.xml · nonDerivative · entry 1 Schulten Andre · CIK 0001844763 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,719.5707 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| December 06, 2023 Filed Dec 8, 2023 16:17 UTC |
Purushothaman BalajiChief Human Resources Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 27.3324 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-029093 · form4.xml · derivative · entry 6 Purushothaman Balaji · CIK 0001957262 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 359.6676 Underlying: Common Stock · 27.3324 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Retirement award in the form of Restricted Stock Units which represent a contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2023. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.